| 1331638 | COPD14_H | Chronic obstructive pulmonary disease QTL 14 (human) | 1.5 | | Chronic airflow obstruction | post-BD FEV1 minus pre-BD FEV1 | 3 | 36484119 | 175785038 | Human | n/a | region | qtl |
| 1331643 | COPD16_H | Chronic obstructive pulmonary disease QTL 16 (human) | 1.07 | | Chronic airflow obstruction | post-BD FEV1 minus pre-BD FEV1/pre-BD FEV1 x 100 | 3 | 49418084 | 197953164 | Human | n/a | region | qtl |
| 1581537 | BP72_H | Blood pressure QTL 72 (human) | 2.1 | .001 | Blood pressure | pulse pressure | 3 | 60258539 | 86258539 | Human | n/a | region | qtl |
| 1559408 | SCL101_H | Serum cholesterol level QTL 101 (human) | 1.77 | .0033 | Lipid level | triglyceride | 3 | 60258539 | 86258539 | Human | n/a | region | qtl |
| 1643454 | SLIPL9_H | Serum lipid level QTL 9 (human) | 1.98 | .001 | Lipid level | | 3 | 60258539 | 86258539 | Human | n/a | region | qtl |
| 1643560 | SADIPOQ13_H | Serum adiponectin level QTL 13 (human) | 2.1 | | Hormone level | adiponectin level | 3 | 64939159 | 100734902 | Human | n/a | region | qtl |
| 2314735 | GLUCO74_H | Glucose level QTL 74 (human) | 1.2 | .005 | Glucose level | non-insulin dependent | 3 | 66811840 | 92811840 | Human | n/a | region | qtl |
| 1578619 | SCL124_H | Serum cholesterol level QTL 124 (human) | 1.8 | | Lipid level | triglyceride-HDL ratio | 3 | 73258381 | 106990108 | Human | n/a | region | qtl |
| 1576347 | COARD3_H | Coronary artery disease susceptibility QTL 3 (human) | 2.42 | | Coronary artery disease susceptibility | early-onset | 3 | 73258381 | 132686410 | Human | n/a | region | qtl |
| 1576344 | COARD1_H | Coronary artery disease susceptibility QTL 1 (human) | 3.5 | .001 | Coronary artery disease susceptibility | early-onset | 3 | 73258381 | 139188599 | Human | n/a | region | qtl |
| 1576333 | COARD2_H | Coronary artery disease susceptibility QTL 2 (human) | 3.16 | | Coronary artery disease susceptibility | early-onset | 3 | 73258381 | 139188599 | Human | n/a | region | qtl |